Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia
This study is ongoing, but not recruiting participants.
Study NCT00513305
Information provided by Cephalon
First Received: August 6, 2007
Last Updated: June 30, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
